Previous Page  10 / 10
Information
Show Menu
Previous Page 10 / 10
Page Background

Page 26

I n t e r n a t i o n a l C o n f e r e n c e o n

Physicians, Surgeons and

Case Reports

November 19-20 , 2018

Par i s , France

Medical Case Reports

ISSN: 2471-8041

PSCR 2018

Introduction:

A 46 year old female was referred to the metabolic medicine

clinic for evaluation. She was referred via her general practitioner with

persistently low alkaline phosphatase (ALP) levels which were first noticed

during an occupational medical assessment. There was no personal history

of fractures or arthritis and no family history of fractures or dental issues.

Commonly considered conditions associated with low serum ALP include

coeliac disease, micronutrient deficiency, Wilson’s disease, drug therapy,

anaemia and hypothyroidism.

Results:

On review, serum ALP was noted to be chronically between 15-20 IU/L

(reference range 30-130 IU/L) and this had been the case for as far back as

results were available which was preceding 13 years. Laboratory testing for

freeT4 andTSHwere normal. In addition, tests for serumcopper, ceruloplasmin

levels, tissue transglutaminase antibodies, vitamin B12, folate and magnesium

levels were all also unremarkable. Zinc was had been previously low but she

had been started on supplementation and levels had normalised by the time

of review. Serum vitamin D was mildly low at 59 nmol/L (reference range is

75-200 nmol/L) and supplementation did not affect her low serum ALP levels.

X-ray imaging of the knees revealed no evidence of chondrocalcinosis. Serum

pyridoxal phosphate levels were elevated at 161.4 nmol/L (reference range

35-110 nmol/L) and also combined with low alkaline phosphatase which

was suggestive of primary hereditary hypophosphatasia. This patient was

referred to a tertiary centre, and urinary phosphoethanolamine was deemed

unnecessary, since it is often normal in patients with hypophosphatasia. This

patient went on to be referred for genetic testing and family screening.

Conclusion:

Primary hereditary hypophosphatasia was initially considered to

be an unlikely diagnosis for this patient since she had been asymptomatic and

did not present with the typical bony symptoms or complications. Monitoring

is usually recommended in patients with primary hereditary hypophosphatasia

and thus, recognition of the condition can have important implications for

patients and their families. Therefore, although uncommon, it is a key diagnosis

to bear in mind.

Biography

Janet Bolaji has completed her BSc in Physiology at King’s

College London in addition to her primary medical qualification

from Swansea University. She completed her Foundation

Training at Frimley Park Hospital and St Helier Hospital. Her

rotations included Chemical Pathology and General Medicine.

She has an interest in Endocrinology and Nutritional Medicine

and is furthering this interest by completing a Masters’ degree

at University College London (UCL). She also has an interest in

medical education and enjoys organising teaching sessions for

medical students.

janetbolaji@yahoo.com

An uncommon cause of low serum alkaline phosphatase (ALP)

Janet Bolaji and Tim Wang

Frimley Park Hospital, UK

Janet Bolaji et al., Med Case Rep. 2018, Volume:4

DOI: 10.21767/2471-8041-C2-005